Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Xu Xu

Hunan Normal University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 8, 2026 · JOURNAL ARTICLE

Dual-organelle–coordinated sonodynamic nanoplatform amplifies immunogenic cell death to drive robust antitumor immunity in cold tumors

Journal of Nanobiotechnology

Early-stage preclinical and patient-derived organoid study of a novel nanoplatform with promising mechanistic data but no clinical trial evidence and reliance on mouse models for efficacy claims.

PreliminaryXu Xu An Xie Qi Yi

Reported

Tumor growth inhibition60–80%

Intratumoral CD8⁺ T-cell infiltra…2–3-fold

Effector memory T cell expansion3-fold

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support